Status:
RECRUITING
Electroacupuncture Modulates SPMs Metabolism and Respiratory Symptoms in Patients With Sepsis Complicating ARDS
Lead Sponsor:
Tianjin Nankai Hospital
Conditions:
Sepsis
Acute Respiratory Distress Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In this interventional clinical trial, researchers will administer electroacupuncture versus sham electroacupuncture to sepsis patients with ARDS and collect objective outcome measures. The study will...
Eligibility Criteria
Inclusion
- Males or females over the age of 18;
- Diagnosis meets SPESIS 3 criteria for sepsis;
- The diagnosis meets the Berlin diagnostic criteria for ARDS;
- ARDS was diagnosed within 48h;
- Capable of understanding the purpose and risk of the study;
- Patients or proxy must give written informed consent before any assessment is performed.
Exclusion
- ARDS was diagnosed 48h later;
- Pregnancy, lactation or perinatal period;
- malignant tumor;
- Severe liver failure or kidney failure;
- Predicted mortality risk of patients within 24h\>80%;
- Severe end-stage lung disease;
- ECMO patients are undergoing implementation;
- HIV seropositive or Syphilis seropositive;
- Any clinical-relevant condition that might affect study participation and/or study results;
- Participation in any other intervention trial;
- Unwillingness or inability to following the study protocol in the investigators opinion.
Key Trial Info
Start Date :
August 20 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 2 2024
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT06006325
Start Date
August 20 2023
End Date
October 2 2024
Last Update
March 26 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tianjin Nankai Hospital
Tianjin, Tianjin Municipality, China, 300000